Coronavirus Update: J&J Shows Promise Against Omicron, UK Nod For Paxlovid
Plus Comirnaty Touted For Teens
The FDA authorized Comirnaty as a booster shot for 12- to 15-year-olds, as J&J's vaccine has shown effectiveness as a booster in Omicron-dominant settings. Meanwhile, Pfizer's Paxlovid won approval in the UK, and Novavax submitted the final data for its vaccine to the FDA.
